Long-term reliability of Medtronic heart rhythm devices in heart patients
Tracks how long Medtronic heart devices keep working in people with arrhythmia.
Plain-language title generated from the registry record
Registry title: Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Key facts
- Where
- Bangalore, Chennai, Gūrgaon, Hyderabad, Jaipur, Kochi, New Delhi, and Vadapalani, IndiaSee the 8 sites
Where in India
- BangaloreBangalore, IndiaTaking people
- ChennaiChennai, IndiaTaking people
- GūrgaonGūrgaon, IndiaTaking people
- HyderabadHyderabad, IndiaTaking people
- JaipurJaipur, IndiaTaking people
- KochiKochi, IndiaTaking people
- New DelhiNew Delhi, IndiaTaking people
- VadapalaniVadapalani, IndiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Medtronic
- Trial code
- NCT00271180
- Record updated
- 4 November 2026
- Original description
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.Read full original descriptionShow less
Medtronic CRDM Product Performance Report
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.
Inclusion: Subject or appropriate legal guardians provide written informed consent and/or authorization for access to and use of health information as required by an institution's IRB/MEC/REB; AND one of the following must also apply:; Subject is indicated for implant or within 30 days post-implant of at least one Medtronic market-released product used for a pacing, sensing or defibrillation application; Subjects who participated in a qualifying study (IDE) of a Medtronic market-released product with complete implant and follow-up data and subject or appropriate legal guardian authorizes release of subject study data.
Exclusion: Subjects receiving an implant of a Medtronic device at a non-participating center and the implant data and current status cannot be confirmed within 30 days after implant; Subjects who are, or will be inaccessible for follow-up; Subjects with exclusion criteria required by local law (EMEA only); Subjects implanted with a Medtronic device whose predetermined enrollment limit for that specific product has been exceeded.
Subjects who meet the following inclusion criteria and do not meet any of the following exclusion criteria are eligible for enrollment.